Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate dose comparison for prevention of pain during etomidate injection
IRCT20090129001615N6Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of magnesium sulfate, lidocaine and etomidate in Injection site pain (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Determination of the effective dose of magnesium sulfate for prevention of pain caused by etomidate injection. Started Sep 2023; status: completed.
02
Drugs
magnesium sulfatelidocaineetomidate
03
Conditions
Injection site pain
Beyond the preview
Go deeper on IRCT20090129001615N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090129001615N6.